Skip to main content

Currently Skimming:

Appendix C: DES Case Study
Pages 237-242

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 237...
... At Tulane University, researchers found that more of the DES-treated women had miscarriages and premature births, while the controls had bigger, healthier babies. At the University of Chicago, every pregnant woman at the University's Lying-In Hospital became part of a clinical trial: one-half were randomized to receive DES and the other half received placebos.
From page 238...
... No malignant tumors have been reported, but certain genital and semen abnormalities are more common in men exposed to DES in utero than in men not exposed to DES. These abnormalities include penile bleeding, testicular masses, epididymal cysts, hypoplastic testes, and cryptorchidism (undescended testicle)
From page 239...
... LIABILITY There have been numerous legal actions initiated by daughters whose mothers were exposed to DES during pregnancy; more than a thousand were pending nationwide as of February 1991 (Squires, 19911. Because over 300 companies manufactured DES according to the same formula and pharmacists often filled prescriptions at random, the chief barrier to recovery for most DES plaintiffs is identifying the manufacturer who supplied the drug that a particular mother ingested.
From page 240...
... In a hearing on whether the case should be dismissed, the court held that Eli Lilly had a duty to notify the plaintiffs about the DES risks when the company became aware of them or should have become aware of them. Under Illinois tort law, however, in order for the plaintiffs to recover under theories of breach of duty to warn and in strict liability, they must allege physical injury to themselves.
From page 241...
... , Falls Church, Va., April 22-24, 1992. Sponsored by the Office of Research on Women's Health, National Cancer Institute, National Institute of Child Health and Human Development and the National Institute of Environmental Sciences.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.